Citation

89 FR 57418

Canonical document for this Federal Register citation.

Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of New Drug Application for EXKIVITY (Mobocertinib Succinate) Capsule, Equivalent to 40 Milligrams Base Monday, July 15, 2024 89 FR 57418